Boehringer Ingelheim produces its own green energy

Boehringer Ingelheim produces its own green energy

Boehringer Ingelheim produces its own green energy

Aerial view of the Ingelheim biomass plant (photo courtesy of Boehringer Ingelheim)

press release notification

  • German Vice Chancellor and Federal Minister of Economics Robert Habeck opens new biomass plant
  • The Ingelheim location can cover 95% of its energy needs with renewable sources
  • New power plant helps achieve company’s global climate goals, saves around 50,000 tons of CO2 per year

Boehringer Ingelheim opened a biomass plant at its Ingelheim site on Monday. With the new power plant, Boehringer Ingelheim is optimizing its energy supply and protecting the environment at the same time: around 50,000 tons of CO2 are saved per year. The CO2 emissions from the site’s own energy generation are reduced by 70%. In total, the company is investing 205 million euros in sustainable infrastructure projects in Ingelheim and can cover 95% of its energy needs on the site with renewable sources in the future.

Describing the commissioning as an “important milestone” for Boehringer Ingelheim, Vice Chairman of the Board of Managing Directors Michael Schmelmer explained: “Part of our sustainability goals is to protect natural resources so that our planet remains a place worth living for people and animals. With an environmentally friendly and more independent energy supply, we ensure stable production to deliver medicines to patients around the world.”

The festive opening was attended by German Vice Chancellor and Minister of Economic Affairs Robert Habeck and Rhineland-Palatinate Environment Minister Katrin Eder.

Federal Minister for Economic Affairs and Climate Action Robert Habeck said: “The decarbonization of all areas of our economy is necessary in order to achieve global climate targets on the one hand and a reduction in energy imports on the other. Boehringer Ingelheim is a good example of this. The company uses renewable energies for production. It trains talents and attracts them as an attractive employer. Last but not least, it invests heavily in research and development, which contributes to better health care and the future-proofing of the site.”

Biomass is an important source of renewable energy and is considered almost CO2 neutral.2 neutral. The waste wood used as fuel in Ingelheim is a waste product. It comes from the Rhine-Main area and is controlled according to strict quality standards.

Inauguration of the biomass plant in Ingelheim (Photo courtesy of Boehringer Ingelheim)

Inauguration of the biomass plant in Ingelheim (Photo courtesy of Boehringer Ingelheim)

Further measures for CO2 neutrality by 2030

The company has set itself the goal of making its operations carbon neutral.2 neutral by 2030. To this end, many individual projects are being implemented worldwide to save energy. By building more energy-efficient buildings, for example, the company has been able to save around 25% percent of its energy requirements per square meter of floor space in Ingelheim to date. The company has also been operating its own solar park in Ingelheim since 2023. Several other Boehringer Ingelheim locations have already been certified as CO2 neutral, for example in Dortmund (Germany), Gainesville (USA), Zhangjian (China) or Sant Cugat (Spain).

About Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s largest investors in research and development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its founding in 1885, Boehringer takes a long-term perspective, embedding sustainability throughout its value chain. More than 53,500 employees serve over 130 markets to create a healthier, more sustainable and fairer future. For more information, visit www.boehringer-ingelheim.com.

Source: Boehringer Ingelheim via GLOBE NEWSWIRE

press release curation and disclaimer notice